Soleus Capital Management, L.P. Immunic, Inc. Transaction History
Soleus Capital Management, L.P.
- $1.21 Billion
- Q1 2025
A detailed history of Soleus Capital Management, L.P. transactions in Immunic, Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 7,293,007 shares of IMUX stock, worth $6.78 Million. This represents 0.66% of its overall portfolio holdings.
Number of Shares
7,293,007
Previous 7,293,007
-0.0%
Holding current value
$6.78 Million
Previous $7.29 Million
8.99%
% of portfolio
0.66%
Previous 0.51%
Shares
4 transactions
Others Institutions Holding IMUX
# of Institutions
70Shares Held
46.9MCall Options Held
1.14MPut Options Held
130K-
Bvf Inc San Francisco, CA8.9MShares$8.28 Million0.43% of portfolio
-
Abrdn PLC8.24MShares$7.67 Million0.01% of portfolio
-
Avidity Partners Management LP Dallas, TX4.45MShares$4.14 Million1.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.93MShares$3.66 Million0.0% of portfolio
-
Gratus Capital LLC2.11MShares$1.96 Million0.1% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $28.4M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...